Lee's Pharmaceutical Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Lee's Pharmaceutical Holdings Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Lee's Pharmaceutical Holdings, the average price target is HK$1.00, with a high estimate of HK$1.00 and a low estimate of HK$1.00. That is a potential downside of approximately -7.41% from the last closing price of HK$1.08 on April, 2024. If you're not interested in 950 stock, you may be interested in its competitors.
-7.41% Downside
Lee's Pharmaceutical Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Lee's Pharmaceutical Holdings's Price has gone down from HK$2.86 to HK$0.00 – a 100.00% drop. Next year, analysts are expecting Fair Value to reach HK$1.82 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1177 Stock Forecast | Sino Biopharmaceutical | Buy |
18
|
HK$2.77 | Buy/Sell | HK$5.10 | 45.13% |
| 43 Stock Forecast | C.P. Pokphand | - |
17
|
HK$1.14 | Buy/Sell | HK$0.12 | -100.00% |
| HCM Stock Forecast | HUTCHMED (China) | Buy |
4
|
£2.90 | Buy/Sell | £5.40 | 70.69% |
| 3933 Stock Forecast | The United Laboratories Intern... | Outperform |
18
|
HK$9.48 | Buy/Sell | HK$10.95 | 8.12% |
| 570 Stock Forecast | China Traditional Chinese Medi... | Buy |
16
|
HK$4.30 | Buy/Sell | HK$3.98 | 0.23% |
Lee's Pharmaceutical Holdings Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Lee's Pharmaceutical Holdings's Revenue has grown from HK$1.22B to HK$1.23B – a 1.35% increase. Next year, analysts are expecting Revenue to reach HK$1.28B – an increase of 3.63%. Over the next seven years, the forecast is for Revenue to grow by 11.81%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 867 Stock Forecast | China Medical System Holdings | Outperform |
18
|
HK$7.20 | Buy/Sell | HK$16.53 | 36.67% |
| 2005 Stock Forecast | SSY Group | Buy |
17
|
HK$4.79 | Buy/Sell | HK$5.99 | 27.35% |
| 512 Stock Forecast | Grand Pharmaceutical Group | Buy |
18
|
HK$4.32 | Buy/Sell | HK$7.60 | -100.00% |
.jpg)
Lee's Pharmaceutical Holdings Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Lee's Pharmaceutical Holdings's Dividend per Share has fallen from HK$0.06 to HK$0.02 – a 66.67% decrease. For next year, analysts predict Dividend per Share of HK$0.03, which would mean an increase of 50.00%. Professionals believe that By 2030, Lee's Pharmaceutical Holdings's Dividend per Share will fall to HK$0.00 – a 100.00% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1112 Stock Forecast | Health and Happiness (H&H) Int... | Buy |
16
|
HK$10.22 | Buy/Sell | HK$14.45 | 33.86% |
| 1230 Stock Forecast | Yashili International Holdings... | - |
11
|
HK$1.20 | Buy/Sell | HK$0.60 | -100.00% |
| 460 Stock Forecast | Sihuan Pharmaceutical Holdings... | Outperform |
16
|
HK$0.56 | Buy/Sell | HK$2.47 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2327 Stock Forecast | Meilleure Health International... | - |
13
|
HK$0.15 | Buy/Sell | HK$1.10 | -100.00% |
| 932 Stock Forecast | Shunten International (Holding... | - |
7
|
HK$0.05 | Buy/Sell | HK$0.00 | -100.00% |
| 239 Stock Forecast | Pak Fah Yeow International | - |
13
|
HK$2.12 | Buy/Sell | HK$0.00 | -100.00% |
Lee's Pharmaceutical Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Lee's Pharmaceutical Holdings's EBITDA has grown, rising from HK$179.94M to HK$237.90M – a growth of 32.21%. In the next year, analysts believe that EBITDA will reach HK$241.38M – an increase of 1.46%. By 2030, professionals predict that Lee's Pharmaceutical Holdings's EBITDA will decrease by 34.96%, to HK$154.73M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 455 Stock Forecast | Tianda Pharmaceuticals | - |
3
|
HK$0.19 | Buy/Sell | HK$0.00 | -100.00% |
| 1498 Stock Forecast | PuraPharm Corporation | - |
0
|
HK$0.85 | Buy/Sell | HK$1.50 | -100.00% |
| 897 Stock Forecast | Wai Yuen Tong Medicine Holding... | - |
0
|
HK$0.23 | Buy/Sell | HK$0.00 | -100.00% |
Lee's Pharmaceutical Holdings EBIT Forecast for 2023 - 2025 - 2030
Lee's Pharmaceutical Holdings's EBIT has grown In the last two years, rising from HK$68.38M to HK$127.44M – a growth of 86.37%. For the following year, the 1 analysts predict that Lee's Pharmaceutical Holdings's EBIT will drop by 17.60%, reaching HK$105.01M. In 2030, the professionals' prediction is that 950's EBIT will decrease by 34.57%, reaching HK$83.38M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 8205 Stock Forecast | Shanghai Jiaoda Withub Informa... | - |
0
|
HK$0.22 | Buy/Sell | HK$0.00 | -100.00% |
| 8120 Stock Forecast | China Demeter Financial Invest... | - |
2
|
HK$0.17 | Buy/Sell | HK$0.00 | -100.00% |
| 858 Stock Forecast | Extrawell Pharmaceutical Holdi... | - |
0
|
HK$0.03 | Buy/Sell | HK$218.63 | -100.00% |
Lee's Pharmaceutical Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Lee's Pharmaceutical Holdings's EPS has gone down from HK$0.22 to HK$0.00 – a 100.00% drop. Next year, analysts are expecting EPS to reach HK$0.14 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)